1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Hydromorphone
1.2.6 Meperidine
1.2.7 Methadone
1.2.8 Others
1.3 Market by Application
1.3.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Relief Application
1.3.3 Anesthesia Application
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcotic (Opioid) Drugs Market Perspective (2017-2028)
2.2 Narcotic (Opioid) Drugs Growth Trends by Region
2.2.1 Narcotic (Opioid) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Narcotic (Opioid) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Narcotic (Opioid) Drugs Market Dynamics
2.3.1 Narcotic (Opioid) Drugs Industry Trends
2.3.2 Narcotic (Opioid) Drugs Market Drivers
2.3.3 Narcotic (Opioid) Drugs Market Challenges
2.3.4 Narcotic (Opioid) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2017-2022)
3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2021
3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
3.7 Date of Enter into Narcotic (Opioid) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcotic (Opioid) Drugs Breakdown Data by Type
4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028)
5 Narcotic (Opioid) Drugs Breakdown Data by Application
5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size (2017-2028)
6.2 North America Narcotic (Opioid) Drugs Market Size by Type
6.2.1 North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
6.2.2 North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
6.2.3 North America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
6.3 North America Narcotic (Opioid) Drugs Market Size by Application
6.3.1 North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
6.3.2 North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
6.3.3 North America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
6.4 North America Narcotic (Opioid) Drugs Market Size by Country
6.4.1 North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
6.4.2 North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size (2017-2028)
7.2 Europe Narcotic (Opioid) Drugs Market Size by Type
7.2.1 Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
7.3 Europe Narcotic (Opioid) Drugs Market Size by Application
7.3.1 Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
7.4 Europe Narcotic (Opioid) Drugs Market Size by Country
7.4.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type
8.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application
8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
8.4.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size (2017-2028)
9.2 Latin America Narcotic (Opioid) Drugs Market Size by Type
9.2.1 Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
9.3 Latin America Narcotic (Opioid) Drugs Market Size by Application
9.3.1 Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country
9.4.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type
10.2.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application
10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
10.4.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Narcotic (Opioid) Drugs Introduction
11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Details
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.3.5 Purdue Pharma Recent Developments
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.4.5 Mallinckrodt Recent Developments
11.5 Amneal Pharma
11.5.1 Amneal Pharma Company Details
11.5.2 Amneal Pharma Business Overview
11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.5.5 Amneal Pharma Recent Developments
11.6 Collegium
11.6.1 Collegium Company Details
11.6.2 Collegium Business Overview
11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.6.5 Collegium Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Narcotic (Opioid) Drugs Introduction
11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.9.5 Mylan Recent Developments
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Details
11.10.2 Hikma Pharmaceuticals Business Overview
11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.10.5 Hikma Pharmaceuticals Recent Developments
11.11 Sun Pharma
11.11.1 Sun Pharma Company Details
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.11.5 Sun Pharma Recent Developments
11.12 Endo Pharmaceuticals
11.12.1 Endo Pharmaceuticals Company Details
11.12.2 Endo Pharmaceuticals Business Overview
11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.12.5 Endo Pharmaceuticals Recent Developments
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.13.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Hydromorphone
Table 6. Key Players of Meperidine
Table 7. Key Players of Methadone
Table 8. Key Players of Others
Table 9. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Narcotic (Opioid) Drugs Market Share by Region (2017-2022)
Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Narcotic (Opioid) Drugs Market Share by Region (2023-2028)
Table 15. Narcotic (Opioid) Drugs Market Trends
Table 16. Narcotic (Opioid) Drugs Market Drivers
Table 17. Narcotic (Opioid) Drugs Market Challenges
Table 18. Narcotic (Opioid) Drugs Market Restraints
Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Narcotic (Opioid) Drugs Revenue Share by Players (2017-2022)
Table 21. Global Top Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021)
Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service
Table 26. Date of Enter into Narcotic (Opioid) Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2017-2022)
Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2023-2028)
Table 32. Global Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Narcotic (Opioid) Drugs Revenue Share by Application (2017-2022)
Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Narcotic (Opioid) Drugs Revenue Share by Application (2023-2028)
Table 36. North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Narcotic (Opioid) Drugs Product
Table 69. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 70. Pfizer Recent Developments
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Narcotic (Opioid) Drugs Product
Table 74. Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 75. Teva Recent Developments
Table 76. Purdue Pharma Company Details
Table 77. Purdue Pharma Business Overview
Table 78. Purdue Pharma Narcotic (Opioid) Drugs Product
Table 79. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 80. Purdue Pharma Recent Developments
Table 81. Mallinckrodt Company Details
Table 82. Mallinckrodt Business Overview
Table 83. Mallinckrodt Narcotic (Opioid) Drugs Product
Table 84. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 85. Mallinckrodt Recent Developments
Table 86. Amneal Pharma Company Details
Table 87. Amneal Pharma Business Overview
Table 88. Amneal Pharma Narcotic (Opioid) Drugs Product
Table 89. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 90. Amneal Pharma Recent Developments
Table 91. Collegium Company Details
Table 92. Collegium Business Overview
Table 93. Collegium Narcotic (Opioid) Drugs Product
Table 94. Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 95. Collegium Recent Developments
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Narcotic (Opioid) Drugs Product
Table 99. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 100. Johnson & Johnson Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Narcotic (Opioid) Drugs Product
Table 104. Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Mylan Company Details
Table 107. Mylan Business Overview
Table 108. Mylan Narcotic (Opioid) Drugs Product
Table 109. Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 110. Mylan Recent Developments
Table 111. Hikma Pharmaceuticals Company Details
Table 112. Hikma Pharmaceuticals Business Overview
Table 113. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 114. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 115. Hikma Pharmaceuticals Recent Developments
Table 116. Sun Pharma Company Details
Table 117. Sun Pharma Business Overview
Table 118. Sun Pharma Narcotic (Opioid) Drugs Product
Table 119. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 120. Sun Pharma Recent Developments
Table 121. Endo Pharmaceuticals Company Details
Table 122. Endo Pharmaceuticals Business Overview
Table 123. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 124. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 125. Endo Pharmaceuticals Recent Developments
Table 126. Allergan Company Details
Table 127. Allergan Business Overview
Table 128. Allergan Narcotic (Opioid) Drugs Product
Table 129. Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 130. Allergan Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcotic (Opioid) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Codeine Features
Figure 3. Fentanyl Features
Figure 4. Hydrocodone Features
Figure 5. Hydromorphone Features
Figure 6. Meperidine Features
Figure 7. Methadone Features
Figure 8. Others Features
Figure 9. Global Narcotic (Opioid) Drugs Market Share by Application: 2021 VS 2028
Figure 10. Pain Relief Application Case Studies
Figure 11. Anesthesia Application Case Studies
Figure 12. Narcotic (Opioid) Drugs Report Years Considered
Figure 13. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Narcotic (Opioid) Drugs Market Share by Region: 2021 VS 2028
Figure 16. Global Narcotic (Opioid) Drugs Market Share by Players in 2021
Figure 17. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2021
Figure 19. North America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 21. North America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 22. North America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 23. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 27. Europe Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 28. Europe Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 29. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Narcotic (Opioid) Drugs Market Size Share by Region (2017-2028)
Figure 39. China Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 49. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 55. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 59. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 60. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 61. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 62. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 63. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 64. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 65. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 66. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 68. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 69. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 70. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
